Infliximab treatment for severe orogenital ulceration in Behcet's disease
- 11 September 2005
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 153 (5) , 1073-1075
- https://doi.org/10.1111/j.1365-2133.2005.06914.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Successful treatment of genital ulcers with infliximab in Behçet's diseaseAnnals of the Rheumatic Diseases, 2004
- Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasisJournal of the American Academy of Dermatology, 2003
- Behçet's disease: a new target for anti-tumour necrosis factor treatmentAnnals of the Rheumatic Diseases, 2002
- Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor alpha antibodyGut, 2001
- Behcet's syndrome: response to infliximab after failure of etanerceptRheumatology, 2001
- Effect of infliximab on sight-threatening panuveitis in Behcet's diseaseThe Lancet, 2001
- Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trialThe Lancet, 2001
- Remission of Behçet's syndrome with tumour necrosis factor α blocking therapyAnnals of the Rheumatic Diseases, 2001
- Treatment of recalcitrant orogenital ulceration of Behcet's syndrome with infliximabRheumatology, 2001
- THALIDOMIDE IN SEVERE OROGENITAL ULCERATIONThe Lancet, 1984